International Journal of Molecular and Cellular Medicine (IJMCM)
Cellular and Molecular Biology Research Center, Babol University of Medical Sciences
جمعه 19 اردیبهشت 1404
[Archive]
جلد 8 -
|
برگشت به فهرست نسخه ها
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Hasanzad M, Larijani B. The Pathway from Gene Therapy to Genome Editing: A Nightmare or Dream. Int J Mol Cell Med 2019; 8 (S1) :69-70
URL: http://ijmcmed.org/article-1-1042-fa.html
URL: http://ijmcmed.org/article-1-1042-fa.html
The Pathway from Gene Therapy to Genome Editing: A Nightmare or Dream. مجله بین المللی سلولی و مولکولی. 1398; 8 (S1) :69-70
: (4885 مشاهده)
The gene therapy approach has largely been improved by the development of new methods in gene transfer and genome editing. The use of CART cells was first approved in 2018 by FDA for ex vivo treatment of B cell acute lymphoblastic leukemia and in vivo treatment of retinal dystrophy. This revolutionary trend is expected to continue as the clinical vision develops and the technical capacity improves.
نوع مطالعه: Letters to the editor |
موضوع مقاله:
Other
دریافت: 1397/12/22 | پذیرش: 1398/8/18 | انتشار: 1398/10/11
دریافت: 1397/12/22 | پذیرش: 1398/8/18 | انتشار: 1398/10/11
| بازنشر اطلاعات | |
 |
این مقاله تحت شرایط Creative Commons Attribution-NonCommercial 4.0 International License قابل بازنشر است. |
